Immunohistochemical Detection of Survivin in Canine Lymphoma

Journal of Comparative Pathology

Volumn 142, Issue 4, 2010, Pages 311-322

  Wimmershoff, J ^a   Polkinghorne, A ^a   Grest, P ^a   Schade, B ^a   Marchal, T ^b   Keller, S M ^a   Guscetti, F ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b VETAGRO SUP   (France)

Author keywords

Dog; Immunohistochemistry; Lymphoma; Survivin

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTISERUM; SURVIVIN;

ADULT ANIMAL; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; CROSS REACTION; CYTOPLASM; DOG DISEASE; FETUS; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPHOMA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CYTOPLASM; DOGS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHOMA; MICROTUBULE-ASSOCIATED PROTEINS;

CANIS FAMILIARIS;

EID: 77952242571     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2009.12.004     Document Type: Article

References (35)

1. Adida C., Crotty P.L., McGrath J., Berrebi D., Diebold J., et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. American Journal of Pathology 1998, 152:43-49.
2. Adida C., Haioun C., Gaulard P., Lepage E., Morel P., et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000, 96:1921-1925.
3. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nature Reviews Cancer 2008, 8:61-70.
4. Altura R.A., Olshefski R.S., Jiang Y., Boue D.R. Nuclear expression of survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. British Journal of Cancer 2003, 89:1743-1749.
5. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine 1997, 3:917-921.
6. Andersen M.H., Svane I.M., Becker J.C., Straten P.T. The universal character of the tumor-associated antigen survivin. Clinical Cancer Research 2007, 13:5991-5994.
7. Chiodino C., Cesinaro A.M., Ottani D., Fantini F., Giannetti A., et al. Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. Journal of Investigative Dermatology 1999, 113:415-418.
8. Crameri F.M., Varvayanis M., Cromie B.R., Rekers W.L., Suter M.M. Serum-free conditions for the long term growth and differentiation of neoplastic canine keratinocytes. Experimental Dermatology 1997, 6:147-155.
9. Ding Y., Prieto V.G., Zhang P.S., Rosenthal S., Smith K.J., et al. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma. Cancer 2006, 106:1123-1129.
10. Fournel-Fleury C., Ponce F., Felman P., Blavier A., Bonnefont C., et al. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Veterinary Pathology 2002, 39:92-109.
11. Fukuda S., Pelus L.M. Survivin, a cancer target with an emerging role in normal adult tissues. Molecular Cancer Therapeutics 2006, 5:1087-1098.
12. Gerl R., Vaux D.L. Apoptosis in the development and treatment of cancer. Carcinogenesis 2005, 26:263-270.
13. Gianani R., Jarboe E., Orlicky D., Frost M., Bobak J., et al. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Human Pathology 2001, 32:119-125.
14. Grossman D., McNiff J.M., Li F., Altieri D.C. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. Journal of Investigative Dermatology 1999, 113:1076-1081.
15. Keller S.M., Keller B.C., Grest P., Borger C.T., Guscetti F. Validation of tissue microarrays for immunohistochemical analyses of canine lymphomas. Journal of Veterinary Diagnostic Investigation 2007, 19:652-659.
16. Keller S.M., Schade B., Rickenbacher A.B., Brugnera E., Wergin M.C., et al. A comprehensive test system to identify suitable antibodies against p53 for immunohistochemical analysis of canine tissues. Journal of Comparative Pathology 2007, 137:59-70.
17. Kobayashi K., Hatano M., Otaki M., Ogasawara T., Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proceedings of the National Academy of Sciences USA 1999, 96:1457-1462.
18. Lechler P., Wu X., Bernhardt W., Campean V., Gastiger S., et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. American Journal of Pathology 2007, 171:1483-1498.
19. Liu L., Zhang M., Zou P. Expression of PLK1 and survivin in diffuse large B-cell lymphoma. Leukemia and Lymphoma 2007, 48:2179-2183.
20. Martinez A., Bellosillo B., Bosch F., Ferrer A., Marce S., et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. American Journal of Pathology 2004, 164:501-510.
21. Moon W.S., Tarnawski A.S. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?. Human Pathology 2003, 34:1119-1126.
22. Murakami M., Sakai H., Kodama A., Mori T., Maruo K., et al. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours. Journal of Comparative Pathology 2008, 139:1-7.
23. Piras F., Murtas D., Minerba L., Ugalde J., Floris C., et al. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Histopathology 2007, 50:835-842.
24. Ponce F., Magnol J.P., Ledieu D., Marchal T., Turinelli V., et al. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Veterinary Journal 2004, 167:158-166.
25. Rebhun R.B., Lana S.E., Ehrhart E.J., Charles J.B., Thamm D.H. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. Journal of Veterinary Internal Medicine 2008, 22:989-995.
26. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nature Reviews Molecular Cell Biology 2002, 3:401-410.
27. Scase T.J., Edwards D., Miller J., Henley W., Smith K., et al. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine 2006, 20:151-158.
28. Schlette E.J., Medeiros L.J., Goy A., Lai R., Rassidakis G.Z. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. Journal of Clinical Oncology 2004, 22:1682-1688.
29. Stauber R.H., Mann W., Knauer S.K. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Research 2007, 67:5999-6002.
30. Tracey L., Perez-Rosado A., Artiga M.J., Camacho F.I., Rodriguez A., et al. Expression of the NF-kappaB targets BCL2 and BIRC5/survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. Journal of Pathology 2005, 206:123-134.
31. Uchide T., Takatsu N., Fujimori Y., Fukushima U., Itoh H. Expression of survivin mRNA in dog tumors. DNA Sequence 2005, 16:329-334.
32. Valli V.E., Jacobs R.M., Parodi A.L., Vernau W., Moore P.F. Histological Classification of Hematopoietic Tumors of Domestic Animals 2002, Vol. VII:189. Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC. 2nd Edit. F.Y. Schulman (Ed.).
33. Velando Rankin W., Henry C.J., Turnquist S.E., Turk J.R., Beissenherz M.E., et al. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. Veterinary and Comparative Oncology 2008, 6:141-150.
34. Vischioni B., Oudejans J.J., Kruyt F.A., Giaccone G., Rodriguez J.A. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies. Histopathology 2007, 50:671-675.
35. Watanuki-Miyauchi R., Kojima Y., Tsurumi H., Hara T., Goto N., et al. Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes. Pathology International 2005, 55:324-330.